Summary

At 1 year following intervention, there apparently is no difference between coronary artery bypass grafting and percutaneous coronary intervention in treating diabetic patients with multivessel disease, as measured by the incidence of a composite of death, myocardial infarction, and stroke. These results are part of the Coronary Artery Revascularization in Diabetes [CARDia; ISRCTN19872154] trial.